Tianyin Pharmaceutical Co Stock Net Income
Tianyin Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianyin Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianyin Stock. The fundamental analysis module provides a way to measure Tianyin Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianyin Pharmaceutical stock.
Tianyin |
Tianyin Pharmaceutical Co Company Net Income Analysis
Tianyin Pharmaceutical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Tianyin Pharmaceutical Net Income | (4.07 M) |
Most of Tianyin Pharmaceutical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianyin Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Tianyin Pharmaceutical Co reported net income of (4.07 Million). This is much lower than that of the sector and significantly lower than that of the Pharmaceutical Products industry. The net income for all United States stocks is notably higher than that of the company.
Tianyin Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianyin Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics of similar companies.Tianyin Pharmaceutical is currently under evaluation in net income category among its peers.
Tianyin Fundamentals
| Return On Asset | -1.24 | |||
| Profit Margin | (13.72) % | |||
| Operating Margin | (7.06) % | |||
| Current Valuation | (7.22 M) | |||
| Shares Outstanding | 29.43 M | |||
| Shares Owned By Insiders | 26.44 % | |||
| Shares Owned By Institutions | 6.40 % | |||
| Number Of Shares Shorted | 112.52 K | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 0.05 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 29.64 M | |||
| Gross Profit | 15.88 M | |||
| Net Income | (4.07 M) | |||
| Cash And Equivalents | 15.16 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 2.94 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 6.64 X | |||
| Cash Flow From Operations | (1.25 M) | |||
| Earnings Per Share | (0.14) X | |||
| Number Of Employees | 1 K | |||
| Beta | 2.79 | |||
| Total Asset | 101.35 M | |||
| Retained Earnings | 50.19 M | |||
| Working Capital | 23.39 M | |||
| Current Asset | 27.53 M | |||
| Current Liabilities | 4.15 M |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |